GLI1 and cancer: SHH binds to the PTCH1 receptor expressed on the cell membrane of osteoblasts and cancer cells, to activate the SHH/PTCH1/GLI1 signaling pathway, which leads to the binding of GLI1 to the promoter of IL-6 and increases the IL-6 expression (Wu et al., 2017; Zhang, 2019).